2017 Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT). Group Chronic Malignancies Working Party (CMWP) 1st listed author Schetelig J Journal Br J Haematol.
2017 Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial). Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger N Journal J Clin Oncol.
2017 High dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: A retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Cook G Journal Haematologica.
2016 Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Heidenreich S Journal Biol Blood Marrow Transplant.
2016 Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting). Group Chronic Malignancies Working Party (CMWP) 1st listed author Bruno B Journal Leuk Lymphoma.
2016 Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meeting. Group Chronic Malignancies Working Party (CMWP) 1st listed author Garderet L Journal Leuk Lymphoma.
2016 Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Robin M Journal Bone Marrow Transplant.
2016 Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party. Group Chronic Malignancies Working Party (CMWP) 1st listed author Sobh M Journal Leukemia
2016 Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease. Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger N Journal N Engl J Med.
2016 Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research. Group Chronic Malignancies Working Party (CMWP) 1st listed author Potter VT Journal Biol Blood Marrow Transplant.
2016 Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party. Group Chronic Malignancies Working Party (CMWP) 1st listed author Koenecke C Journal Bone Marrow Transplant.
2016 Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Paviglianiti A Journal Haematologica.